Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 1631 entries
View as:

Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease

Phase: N/A Priority: Normal
NCT ID: NCT01690533 Org: User:
Start: 05/13/08 End: 07/19/13 Due: 07/19/14

Effect of Ketoconazole on Regorafenib (BAY73-4506) Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT01318265 Org: User:
Start: 03/31/11 End: 07/31/11 Due: 07/31/12

Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm

Phase: N/A Priority: Normal
NCT ID: NCT02900404 Org: User:
Start: 02/15/17 End: 03/31/17 Due: 03/31/18

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT03597022 Org: User:
Start: 07/24/18 End: 10/15/19 Due: 10/15/20

Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)

Phase: N/A Priority: Normal
NCT ID: NCT04498156 Org: User:
Start: 09/16/20 End: 04/30/21 Due: 04/30/22

Actual Use Trial of Naproxen Sodium

Phase: N/A Priority: Normal
NCT ID: NCT01427803 Org: User:
Start: 09/30/11 End: 12/31/11 Due: 12/31/12

Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years

Phase: N/A Priority: Normal
NCT ID: NCT01389271 Org: User:
Start: 02/03/11 End: 06/18/18 Due: 06/18/19

A Study to Learn How Well a Single Dose of the Study Treatment Naproxen Sodium and Caffeine Combined in One Tablet (Fixed-dose Combination) Works to Relieve Pain After Dental Surgeries Compared to the Single Ingredients and to Placebo

Phase: N/A Priority: Normal
NCT ID: NCT05485805 Org: User:
Start: 09/21/22 End: 01/29/24 Due: 01/29/25

Kogenate FS Regulatory Post-Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01386268 Org: User:
Start: 06/30/11 End: 08/31/13 Due: 08/31/14

A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00492752 Org: User:
Start: 10/31/05 End: 07/31/09 Due: 07/31/10

Eylea Post Marketing Surveillance(PMS)

Phase: N/A Priority: Normal
NCT ID: NCT01783925 Org: User:
Start: 04/29/14 End: 12/31/18 Due: 12/31/19

Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea

Phase: N/A Priority: Normal
NCT ID: NCT00461305 Org: User:
Start: 02/28/07 End: 08/31/09 Due: 08/31/10

Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea Paste

Phase: N/A Priority: Normal
NCT ID: NCT00781820 Org: User:
Start: 10/31/08 End: 01/31/10 Due: 01/31/11

Efficacy and Safety of SH T00660AA in Treatment of Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT00225199 Org: User:
Start: 03/31/04 End: 09/30/06 Due: 09/30/07

Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.

Phase: N/A Priority: Normal
NCT ID: NCT00622479 Org: User:
Start: 05/31/08 End: 11/30/10 Due: 11/30/11

Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01021436 Org: User:
Start: 03/31/07 End: 08/31/07 Due: 08/31/08

Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)

Phase: N/A Priority: Normal
NCT ID: NCT04531813 Org: User:
Start: 06/10/13 End: 07/01/13 Due: 07/01/14

BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT00623727 Org: User:
Start: 06/30/08 End: 10/31/10 Due: 10/31/11

The VERIFY Study: An Observational Study Called VERIFY to Learn More About the Use of Vericiguat in People With Chronic Heart Failure With Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT05974189 Org: User:
Start: 07/11/23 End: 10/08/24 Due: 10/08/25

Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter

Phase: N/A Priority: Normal
NCT ID: NCT01839357 Org: User:
Start: 08/31/13 End: 12/31/14 Due: 12/31/15

Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01028079 Org: User:
Start: 11/30/05 End: 12/31/06 Due: 12/31/07

A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT02976467 Org: User:
Start: 12/30/16 End: 09/04/18 Due: 09/04/19

A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT06195930 Org: User:
Start: 04/18/24 End: 07/29/24 Due: 07/29/25

FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period

Phase: N/A Priority: Normal
NCT ID: NCT00921245 Org: User:
Start: 06/30/07 End: 02/28/09 Due: 02/28/10

Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT02865538 Org: User:
Start: 08/01/16 End: 03/28/17 Due: 03/28/18